JUDY HOLDER: Open Payments
NPI 1912469339 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 12 payments from 7 companies in 2025. Trend: 2023 $335 · 2024 $320 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $105 |
| ViiV Healthcare Company | 2 | $55 |
| Novo Nordisk Inc | 2 | $39 |
| Lilly USA, LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: Ozempic, DOVATO, MOUNJARO, Yeztugo, GARDASIL 9, APRETUDE, APTIMA, REPATHA.
Industry payments across NY — which companies pay providers there.
